Search Results - "WANG, S. E"

Refine Results
  1. 1

    Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM by Wang, Y, Yu, Y, Tsuyada, A, Ren, X, Wu, X, Stubblefield, K, Rankin-Gee, E K, Wang, S E

    Published in Oncogene (24-03-2011)
    “…Recent studies indicate that a subset of cancer cells possessing stem cell properties, referred to as cancer-initiating or cancer stem cells (CSCs), have…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease by Wang, E.-S., Sun, Y., Guo, J.-G., Gao, X., Hu, J.-W., Zhou, L., Hu, J., Jiang, C.-C.

    Published in Acta neurologica Scandinavica (01-11-2010)
    “…Wang E‐S, Sun Y, Guo J‐G, Gao X, Hu J‐W, Zhou L, Hu J, Jiang C‐C. Tetranectin and apolipoprotein A‐I in cerebrospinal fluid as potential biomarkers for…”
    Get full text
    Journal Article
  4. 4

    H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3 by Chakrabarty, A, Rexer, B N, Wang, S E, Cook, R S, Engelman, J A, Arteaga, C L

    Published in Oncogene (16-09-2010)
    “…Hyperactivation of phosphatidylinositol-3 kinase (PI3K) can occur as a result of somatic mutations in PIK3CA , the gene encoding the p110α subunit of PI3K. The…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases by Shivakumar, R., Tan, W., Wilding, G.E., Wang, E.S., Wetzler, M.

    Published in Annals of oncology (01-09-2008)
    “…Secondary acute lymphoblastic leukemia (sALL) is a rare disease and its biologic features are not well characterized. We describe a cohort of seven patients…”
    Get full text
    Journal Article
  7. 7

    Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators by Wang, S E, Yu, Y, Criswell, T L, DeBusk, L M, Lin, P C, Zent, R, Johnson, D H, Ren, X, Arteaga, C L

    Published in Oncogene (10-06-2010)
    “…Activating mutations in the tyrosine kinase domain of HER2 (ErbB2) have been identified in human cancers. Compared with wild-type HER2, mutant HER2 shows…”
    Get full text
    Journal Article
  8. 8

    The clinical efficacy of neuronavigation-assisted minimally invasive operation on hypertensive basal ganglia hemorrhage by Yan, Y-F, Ru, D-W, Du, J-R, Shen, X, Wang, E-S, Yao, H-B

    “…To explore the therapeutic effect of neuronavigation-assisted minimally invasive operation on hypertensive basal ganglia hemorrhage patients with hematoma…”
    Get more information
    Journal Article
  9. 9

    Molecular Epidemiology and Risk Factors for Colonization by Vancomycin-Resistant Enterococcus in Patients with Hematologic Malignancies by Almyroudis, N. G., Lesse, A. J., Hahn, T., Samonis, G., Hazamy, P. A., Wongkittiroch, K., Wang, E. S., McCarthy Jr, P. L., Wetzler, M., Segal, B. H.

    “…Objective. To study the molecular epidemiology of vancomycin-resistant Enterococcus (VRE) colonization and to identify modifiable risk factors among patients…”
    Get full text
    Journal Article
  10. 10

    The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia by Eisfeld, A-K, Mrózek, K, Kohlschmidt, J, Nicolet, D, Orwick, S, Walker, C J, Kroll, K W, Blachly, J S, Carroll, A J, Kolitz, J E, Powell, B L, Wang, E S, Stone, R M, de la Chapelle, A, Byrd, J C, Bloomfield, C D

    Published in Leukemia (01-10-2017)
    “…Recurrent chromosomal abnormalities and gene mutations detected at the time of diagnosis of acute myeloid leukemia (AML) are associated with particular disease…”
    Get full text
    Journal Article
  11. 11

    Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503) by Blum, W, Sanford, B L, Klisovic, R, DeAngelo, D J, Uy, G, Powell, B L, Stock, W, Baer, M R, Kolitz, J E, Wang, E S, Hoke, E, Mrózek, K, Kohlschmidt, J, Bloomfield, C D, Geyer, S, Marcucci, G, Stone, R M, Larson, R A

    Published in Leukemia (01-01-2017)
    “…In this prospective phase 2 clinical trial conducted by Cancer and Leukemia Group B (CALGB, now the Alliance), we studied decitabine as maintenance therapy for…”
    Get full text
    Journal Article
  12. 12

    Risk factors and outcomes of conversion in minimally invasive distal pancreatectomy: a systematic review by Balduzzi, A., van der Heijde, N., Alseidi, A., Dokmak, S., Kendrick, M. L., Polanco, P. M., Sandford, D. E., Shrikhande, S. V., Vollmer, C. M., Wang, S. E., Zeh, H. J., Hilal, M. Abu, Asbun, H. J., Besselink, M. G.

    Published in Langenbeck's archives of surgery (01-05-2021)
    “…Purpose The reported conversion rates for minimally invasive distal pancreatectomy (MIDP) range widely from 2 to 38%. The identification of risk factors for…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20